CA2923390A1 - Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota - Google Patents
Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota Download PDFInfo
- Publication number
- CA2923390A1 CA2923390A1 CA2923390A CA2923390A CA2923390A1 CA 2923390 A1 CA2923390 A1 CA 2923390A1 CA 2923390 A CA2923390 A CA 2923390A CA 2923390 A CA2923390 A CA 2923390A CA 2923390 A1 CA2923390 A1 CA 2923390A1
- Authority
- CA
- Canada
- Prior art keywords
- lactobacillus
- microorganisms
- composition
- placebo
- faecal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/10—Enterobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001473A ITMI20131473A1 (it) | 2013-09-06 | 2013-09-06 | Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale |
| ITMI2013A001473 | 2013-09-06 | ||
| PCT/IB2014/064284 WO2015033304A1 (en) | 2013-09-06 | 2014-09-05 | Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2923390A1 true CA2923390A1 (en) | 2015-03-12 |
Family
ID=49354801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2923390A Pending CA2923390A1 (en) | 2013-09-06 | 2014-09-05 | Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota |
Country Status (13)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| CN108350508B (zh) * | 2015-10-29 | 2021-09-17 | 株式会社益力多本社 | 雌马酚产生能力的测定方法 |
| IT201600083376A1 (it) | 2016-08-08 | 2018-02-08 | Sofar Spa | Uso di probiotici per aumentare l’assorbimento proteico |
| ITUA20164188A1 (it) * | 2016-06-08 | 2017-12-08 | Sofar Spa | Nuovo uso medico di probiotici |
| CN106318890A (zh) * | 2016-10-21 | 2017-01-11 | 山东省农业科学院畜牧兽医研究所 | 一株分离自spf鸡嗉囊的产植酸酶卷曲乳杆菌菌株及其应用 |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| IT201700101704A1 (it) * | 2017-09-12 | 2019-03-12 | Sofar Spa | Nuovo uso per trattamento delle infezioni da clostridium difficile |
| CN111936639A (zh) * | 2018-01-17 | 2020-11-13 | 生物技术网络研究中心联合会 | 针对降低受试者中的循环琥珀酸盐水平的靶向干预，以及用于确定所述干预的有效性的试剂盒和方法 |
| CN112384227A (zh) | 2018-02-09 | 2021-02-19 | N·V·努特里奇亚 | 含有不可消化寡糖的发酵配方物 |
| JP2021520191A (ja) * | 2018-04-02 | 2021-08-19 | サン ジェノミクス インコーポレイテッド | 試料中の１つ以上の種類の微生物の多様な集団から核酸分子を抽出するための万能な方法 |
| CN110029155A (zh) * | 2019-05-27 | 2019-07-19 | 天益健康科学研究院（镇江）有限公司 | 一种基于荧光定量pcr组合式肠道细菌检测方法 |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| CN112980712A (zh) * | 2019-12-14 | 2021-06-18 | 山东大学 | 一种调节高原人群情绪及肠道菌群稳定的微生物组合物及其应用 |
| CN116287163A (zh) * | 2023-02-17 | 2023-06-23 | 浙江大学 | 一种评估肠道菌群对菊粉的动态响应方法 |
| EP4575491A1 (en) | 2023-12-22 | 2025-06-25 | Vilnius University | Method for detecting volatile organic compounds in faecal matter odour |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040170617A1 (en) * | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| AU2002951270A0 (en) * | 2002-09-06 | 2002-09-19 | Vri Biomedical Ltd | Probiotic Bacterium and Methods of Use |
| WO2005001109A2 (en) * | 2003-05-06 | 2005-01-06 | Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health | Methods and compositions to detect microbes in fecal samples |
| WO2005083122A2 (en) * | 2004-02-27 | 2005-09-09 | Stichting Laboratorium Voor Infectieziekten | Method for detecting a microorganism in a fecal specimen |
| EP1815016B1 (en) * | 2004-11-01 | 2012-06-27 | George Mason University | Compositions and methods for diagnosing colon disorders |
| FI20051319L (fi) * | 2005-12-22 | 2007-06-23 | Cyflo Oy | Menetelmä eläimen ja/tai ihmisen ravitsemuksen ja hyvinvoinnin ja eläinten tuottavuuden seuraamiseksi ja kehittämiseksi |
| CN1840206A (zh) * | 2006-01-19 | 2006-10-04 | 上海交通大学 | 人源菌群仔猪模型的构建及仔猪肠道中菌群分子检测方法 |
| ES2426038T3 (es) * | 2006-02-21 | 2013-10-18 | National University Corporation University Of Toyama | Procedimiento rápido para identificar el microorganismo causante de una enfermedad infecciosa |
| CN101240315A (zh) * | 2008-02-21 | 2008-08-13 | 上海交通大学 | 检测药物防癌效果的非损伤性分子方法 |
| JP2010161944A (ja) * | 2009-01-13 | 2010-07-29 | Syngen Biotech Co Ltd | 新型カゼイ菌の亜種（ｓｇ９６）及びこれを含有する菌抑制組成物及びその用途 |
-
2013
- 2013-09-06 IT IT001473A patent/ITMI20131473A1/it unknown
-
2014
- 2014-09-05 EA EA201690465A patent/EA034795B1/ru unknown
- 2014-09-05 EA EA202090097A patent/EA202090097A1/ru unknown
- 2014-09-05 SG SG11201601664VA patent/SG11201601664VA/en unknown
- 2014-09-05 US US14/916,959 patent/US20160348155A1/en not_active Abandoned
- 2014-09-05 JP JP2016539666A patent/JP6701078B2/ja not_active Expired - Fee Related
- 2014-09-05 MX MX2016002766A patent/MX2016002766A/es unknown
- 2014-09-05 CA CA2923390A patent/CA2923390A1/en active Pending
- 2014-09-05 CN CN201480049288.XA patent/CN105518150A/zh active Pending
- 2014-09-05 WO PCT/IB2014/064284 patent/WO2015033304A1/en not_active Ceased
- 2014-09-05 BR BR112016005064A patent/BR112016005064A2/pt not_active Application Discontinuation
- 2014-09-05 HK HK16112010.3A patent/HK1223982A1/zh unknown
- 2014-09-05 EP EP14790322.3A patent/EP3047032A1/en not_active Withdrawn
-
2016
- 2016-03-02 MX MX2022013625A patent/MX2022013625A/es unknown
- 2016-03-02 IL IL244391A patent/IL244391B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016528926A (ja) | 2016-09-23 |
| US20160348155A1 (en) | 2016-12-01 |
| ITMI20131473A1 (it) | 2015-03-07 |
| EP3047032A1 (en) | 2016-07-27 |
| EA034795B1 (ru) | 2020-03-23 |
| IL244391B (en) | 2021-02-28 |
| MX2016002766A (es) | 2016-08-03 |
| WO2015033304A1 (en) | 2015-03-12 |
| IL244391A0 (en) | 2016-04-21 |
| HK1223982A1 (zh) | 2017-08-11 |
| SG11201601664VA (en) | 2016-04-28 |
| EA202090097A1 (ru) | 2020-04-07 |
| MX2022013625A (es) | 2022-11-16 |
| CN105518150A (zh) | 2016-04-20 |
| JP6701078B2 (ja) | 2020-05-27 |
| EA201690465A1 (ru) | 2016-08-31 |
| BR112016005064A2 (pt) | 2017-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20160348155A1 (en) | Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota | |
| US20240050497A1 (en) | Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid | |
| US20190290706A1 (en) | New medical use of probiotics | |
| Derrien et al. | Fate, activity, and impact of ingested bacteria within the human gut microbiota | |
| Unno et al. | Changes in human gut microbiota influenced by probiotic fermented milk ingestion | |
| US20190030098A1 (en) | Treatment of clostridium difficile infection | |
| EP3870196A1 (en) | Bacterial strains of the lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract | |
| Matsumoto et al. | Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt | |
| CN118203603B (zh) | 一种后生元及其在调节脂代谢方向的应用 | |
| US12194142B2 (en) | Bacillus subtilis containing composition for treatment of gastrointestinal irregularity | |
| RU2546253C2 (ru) | Способ получения персонифицированного аутопробиотического продукта и способ лечения синдрома раздраженной кишки с использованием этого продукта | |
| AU2022228145A1 (en) | Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota | |
| WO2019113023A9 (en) | Probiotics and methods of use | |
| AU2014316687A1 (en) | Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota | |
| Chakraborty et al. | Review on probiotics as a health supplement | |
| HK40101402A (en) | New medical use of probiotics | |
| HK40000411A (en) | New medical use of probiotics | |
| HK40090429A (en) | Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190611 |